Anti-lymphocyte serum (low-dose)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-lymphocyte serum (low-dose), covering 2024-02-20 to 2024-02-20. Get the full timeline:
Most recent: Clinical Trial Update: PROPHYLAXIS OF GVH IN ELDERLY PATIENTS RECEIVING HAPLOIDENTICAL ALLOGENIC HEMATOPOIETIC STEM CELL TRASNPLANTATION USE OF A LOW DOSE ANTI-LYMPHOCYTIC SERUM [Phase 2]